Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.6.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 3,735 $ 5,385
INVESTING ACTIVITIES    
Acquisition of business (200) (5,899)
Purchase of medical equipment and property (6,997) (9,390)
Proceeds from sale of medical equipment and property 2,511 2,599
NET CASH USED IN INVESTING ACTIVITIES (4,686) (12,690)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (44,197) (52,681)
Cash proceeds from revolving credit facility 45,327 60,605
Debt issuance costs   (157)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (50) (144)
Cash proceeds from stock plans 125 156
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,205 7,779
Net change in cash and cash equivalents 254 474
Cash and cash equivalents, beginning of period 818 515
Cash and cash equivalents, end of period $ 1,072 $ 989